As viral vector gene therapy processes reach the clinical and manufacturing stages, the ability to scale up those processes becomes crucial. In this study we demonstrate how the Thermo Scientific HyPerforma DynaDrive Single-Use Bioreactor (S.U.B.) offers optimal conditions for growth and transfection of Gibco Viral Production Cells (VPC1.0 and VPC2.0 cells), both derivatives of HEK 293F cells, utilizing the Gibco LV-MAX Production System and the Gibco AAV-MAX Production System. We also show scalability of cell growth from flask to HyPerforma DynaDrive S.U.B. in 50L, 500L, and 3000L sizes, offering particular guidance on key scale factors and experience to ensure process success
Background: Lentiviral vectors (LV) offer several advantages over other gene delivery vectors. Their...
The field of gene therapy has changed drastically since the first human gene transfer experiment con...
Through the delivery of recombinant adeno-associated virus (rAAV) vectors, gene therapy has the pote...
Lentiviral vectors (LVV) represent an important tool for cell and gene therapy applications. However...
With several recent FDA approvals and a strong drug pipeline, gene therapy is coming of age. With th...
A novel single-use bioreactor was recently introduced to the market that is agitated by impellers su...
Scalable lentiviral vector (LV) manufacturing is vital for successful commercialization of LV-based ...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Lentiviral vectors are widely used in the field of gene therapy as an effective method for permanent...
g-retroviral vectors expressing chimeric antigen receptors or T-cell receptors for phase II clinical...
Lentiviral vectors (LV) represent a key tool for gene and cell therapy applications. The production ...
AAV-based gene therapy vectors are under intense investigation and rapidly becoming established as c...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Cell and gene engineering has transformed the landscape of treatment for patients. Viral vectors suc...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Background: Lentiviral vectors (LV) offer several advantages over other gene delivery vectors. Their...
The field of gene therapy has changed drastically since the first human gene transfer experiment con...
Through the delivery of recombinant adeno-associated virus (rAAV) vectors, gene therapy has the pote...
Lentiviral vectors (LVV) represent an important tool for cell and gene therapy applications. However...
With several recent FDA approvals and a strong drug pipeline, gene therapy is coming of age. With th...
A novel single-use bioreactor was recently introduced to the market that is agitated by impellers su...
Scalable lentiviral vector (LV) manufacturing is vital for successful commercialization of LV-based ...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Lentiviral vectors are widely used in the field of gene therapy as an effective method for permanent...
g-retroviral vectors expressing chimeric antigen receptors or T-cell receptors for phase II clinical...
Lentiviral vectors (LV) represent a key tool for gene and cell therapy applications. The production ...
AAV-based gene therapy vectors are under intense investigation and rapidly becoming established as c...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Cell and gene engineering has transformed the landscape of treatment for patients. Viral vectors suc...
Lentiviral vectors (LV) have played a critical role in gene delivery for ex vivo gene-modified cell ...
Background: Lentiviral vectors (LV) offer several advantages over other gene delivery vectors. Their...
The field of gene therapy has changed drastically since the first human gene transfer experiment con...
Through the delivery of recombinant adeno-associated virus (rAAV) vectors, gene therapy has the pote...